Sunbird Bio Raises Additional $14 Million to Advance Broadest Blood-Based Diagnostic Platform in Alzheimer’s Disease and Other Neurological Disorders
Financing includes new funding from leading global organizations Eli Lilly and Company and EDBI
- 16 10 2024
- |